The AstraZeneca Covid-19 vaccine can inhibit blood clots in rare cases
The benefits of Oxford / Astrazeneca Covid-19 vaccine continue to exceed the risk Oxford / AstraZeneca Coronavirus Vaccines can be associated with a slight risk of increasing from some bleeding disorders, according to new data, but such cases are very rare and the benefits of vaccines continue to exceed the risks, the researchers said. Analysis of people who receive the first dose of Oxford / Astrazeneca or Pfizer Vaccine / Bionech reveal a small increase in t he conditions of autoimmune bleeding known as the Purpura Trombocytopenic immune (ITP) associated with Oxford / Astrazeneca vaccines, separate by blood clotting. The syndrome was linked to the previous vaccine. In ITP, the immune system destroys platelets, blood cells that help blood become lumps. This condition can cause minor bruises in some people and excessive bleeding and long-term diseases in others, but the symptoms are usually mild and die from ITP very rarely. It is estimated that occur at around 11 people for eve...